A 35-year-old man from Mumbai presents with a 4-month history of a painless, slowly enlarging warty lesion on the glans penis. The lesion is exophytic with a cauliflower-like appearance. HPV testing identifies HPV-11. What is the most appropriate management?

Explanation

## HPV-11 and Benign Genital Warts: Management Strategy ### HPV Type Classification and Risk Stratification **Key Point:** HPV types are classified as low-risk (6, 11, 42, 43, 44) or high-risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68). This classification determines malignant potential and management approach. **High-Yield:** HPV-11 is a **low-risk type** with malignant potential <1%. It causes benign genital warts and recurrent respiratory papillomatosis (RRP) in children, neither of which progress to malignancy in the vast majority of cases. ### Natural History of Low-Risk HPV Infection | Characteristic | Low-Risk HPV (6, 11) | High-Risk HPV (16, 18, 31, 33) | | --- | --- | --- | | Malignant potential | <1% | >30–50% if persistent | | Typical lesion | Exophytic warts (condyloma) | Flat/endophytic dysplasia | | Natural history | Spontaneous regression in 60–90% | Persistence/progression to CIN/cancer | | Transformation time | Rare | 3–10 years | | Management | Observation or symptomatic treatment | Excision + HPV surveillance | **Clinical Pearl:** The cauliflower-like, exophytic appearance is classic for **benign condyloma acuminatum** caused by low-risk HPV. This morphology is protective against malignancy. ### Rationale for Observation 1. **Spontaneous regression:** 60–90% of low-risk HPV infections clear spontaneously within 1–2 years due to cell-mediated immunity. 2. **No malignant potential:** HPV-11 does not encode the high-affinity E6/E7 oncoproteins needed to inactivate p53 and Rb. 3. **Avoid overtreatment:** Unnecessary interventions carry morbidity (scarring, dyspareunia, psychological impact) without survival benefit. 4. **Immune competence:** In immunocompetent individuals, spontaneous clearance is the rule. **Mnemonic:** **LRWART** — Low-Risk Warts Are Rarely Transformed (observation is safe). ### When Treatment Is Indicated Treatment (topical imiquimod, podofillin, cryotherapy, or laser) is offered only if: - Lesions are **symptomatic** (pain, bleeding, obstruction) - Patient **requests removal** for cosmetic/sexual reasons - Lesions are **rapidly enlarging** (rare) Treatment does **not** reduce malignant risk (which is already <1%) but may improve symptoms or patient satisfaction.